HIV Citation List: December 10 - December 21, 2010

Pubmed citations:

1. Synthesis and Biological Evaluation of Aryl-phospho-indole as Novel HIV-1 Non-nucleoside Reverse Transcriptase Inhibitors. Alexandre, F.R., A. Amador, S. Bot, C. Caillet, T. Convard, J. Jakubik, C. Musiu, B. Poddesu, L. Vargiu, M. Liuzzi, A. Roland, M. Seifer, D. Standring, R. Storer, and C.B. Dousson. Journal of Medicinal Chemistry, 2010. [Epub ahead of print]; PMID[21142105].

[Pubmed]. HIV_1210-122110.

2. HIV Capsid is a Tractable Target for Small Molecule Therapeutic Intervention. Blair, W.S., C. Pickford, S.L. Irving, D.G. Brown, M. Anderson, R. Bazin, J. Cao, G. Ciaramella, J. Isaacson, L. Jackson, R. Hunt, A. Kjerrstrom, J.A. Nieman, A.K. Patick, M. Perros, A.D. Scott, K. Whitby, H. Wu, and S.L. Butler. PLoS Pathogens, 2010. 6(12): p. e1001220; PMID[21170360].

[Pubmed]. HIV_1210-122110.

3. Recent Advances in DAPYs and Related Analogues as HIV-1 NNRTIs. Chen, X., P. Zhan, D. Li, E. De Clercq, and X. Liu. Current Medicinal Chemistry, 2010. [Epub ahead of print]; PMID[21143120].

[Pubmed], HIV_1210-122110.

4. Discovery and applications of the plant cyclotides.Craik, D.J. Toxicon, 2010. 56(7): p. 1092-1102; PMID[20219513].

[Pubmed]. HIV_1210-122110.

5. Discovery of N-benzyl-N'-(4-pipyridinyl)urea CCR5 antagonists as anti-HIV-1 agents (I): optimization of the amine portion. Duan, M., J. Peckham, M. Edelstein, R. Ferris, W.M. Kazmierski, A. Spaltenstein, P. Wheelan, and Z. Xiong. Bioorganic & Medicinal Chemistry Letters, 2010. 20(24): p. 7397-7400; PMID[21035337].

[Pubmed]. HIV_1210-122110.

6. Potential of polymeric nanoparticles in AIDS treatment and prevention. Khalil, N.M., E. Carraro, L.F. Cotica, and R.M. Mainardes. Expert Opinion on Drug Delivery, 2010. [Epub ahead of print]; PMID[21143001].

[Pubmed]. HIV_1210-122110.

7. Novel, Selective CDK9 Inhibitors for the Treatment of HIV Infection. Nemeth, G., Z. Varga, Z. Greff, G. Bencze, A. Sipos, C. Szantai-Kis, F. Baska, A. Gyuris, K. Kelemenics, Z. Szathmary, J. Minarovits, G. Keri, and L. Orfi. Current Medicinal Chemistry, 2010. [Epub ahead of print]; PMID[21143121].

[Pubmed]. HIV_1210-122110.

8. Tetra-end-linked oligonucleotides forming DNA G-quadruplexes: a new class of aptamers showing anti-HIV activity. Oliviero, G., J. Amato, N. Borbone, S. D'Errico, A. Galeone, L. Mayol, S. Haider, O. Olubiyi, B. Hoorelbeke, J. Balzarini, and G. Piccialli. Chemical Communications (Cambridge, England), 2010. 46(47): p. 8971-8973; PMID[20972507].

[Pubmed]. HIV_1210-122110.

9. Enzymatic De Novo Pyrimidine Nucleotide Synthesis. Schultheisz, H.L., B.R. Szymczyna, L.G. Scott, and J.R. Williamson. Journal of the American Chemical Society, 2010. [Epub ahead of print]; PMID[21166398].

[Pubmed]. HIV_1210-122110.

10. Resistance profiles of novel electrostatically constrained HIV-1 fusion inhibitors. Shimura, K., D. Nameki, K. Kajiwara, K. Watanabe, Y. Sakagami, S. Oishi, N. Fujii, M. Matsuoka, S.G. Sarafianos, and E.N. Kodama. Journal of Biological Chemistry, 2010. 285(50): p. 39471-39480; PMID[20937812].

[Pubmed]. HIV_1210-122110.

11. Azaindole N-methyl hydroxamic acids as HIV-1 integrase inhibitors-II. The impact of physicochemical properties on ADME and PK. Tanis, S.P., M.B. Plewe, T.W. Johnson, S.L. Butler, D. Dalvie, D. DeLisle, K.R. Dress, Q. Hu, B. Huang, J.E. Kuehler, A. Kuki, W. Liu, Q. Peng, G.L. Smith, J. Solowiej, K.T. Tran, H. Wang, A. Yang, C. Yin, X. Yu, J. Zhang, and H. Zhu. Bioorganic & Medicinal Chemistry Letters, 2010. 20(24): p. 7429-7434; PMID[21036042].

[Pubmed]. HIV_1210-122110.

12. Gyrase B inhibitor impairs HIV-1 replication by targeting Hsp90 and the capsid protein. Vozzolo, L., B. Loh, P.J. Gane, M. Tribak, L. Zhou, I. Anderson, E. Nyakatura, R.G. Jenner, D. Selwood, and A. Fassati. Journal of Biological Chemistry, 2010. 285(50): p. 39314-39328; PMID[20937817].

[Pubmed]. HIV_1210-122110.

13. Fragment-Based Design of Ligands Targeting a Novel Site on the Integrase Enzyme of Human Immunodeficiency Virus 1. Wielens, J., S.J. Headey, J.J. Deadman, D.I. Rhodes, M.W. Parker, D.K. Chalmers, and M.J. Scanlon. ChemMedChem, 2010. [Epub ahead of print]; PMID[21165936].

[Pubmed]. HIV_1210-122110.

14. Huwe1, a novel cellular interactor of Gag-Pol through integrase binding, negatively influences HIV-1 infectivity. Yamamoto, S.P., K. Okawa, T. Nakano, K. Sano, K. Ogawa, T. Masuda, Y. Morikawa, Y. Koyanagi, and Y. Suzuki. Microbes and Infection, 2010. [Epub ahead of print]; PMID[21167302].

[Pubmed]. HIV_1210-122110.

ISI Web of Knowledge citations:

15. Amyloid-binding Small Molecules Efficiently Block SEVI (Semen-derived Enhancer of Virus Infection)- and Semen-mediated Enhancement of HIV-1 Infection. Olsen, J.S., C. Brown, C.C. Capule, M. Rubinshtein, T.M. Doran, R.K. Srivastava, C.Y. Feng, B.L. Nilsson, J. Yang, and S. Dewhurst. Journal of Biological Chemistry, 2010. 285(46): p. 35488-35496; ISI[000283845300027].

[WOS]. HIV_1210-122110.

16. Synthesis of Baylis-Hillman-Derived Phosphonated 3-(Benzylaminomethyl)coumarins. Rashamuse, T.J., R. Klein, and P.T. Kaye. Synthetic Communications, 2010. 40(24): p. 3683-3690; ISI[000284005600012].

[WOS]. HIV_1210-122110.

17. Molecular Iodine: An Efficient and Environment Friendly Catalyst for the Synthesis of 3,5-Bis-(arylmethylidene)-tetrahydropyran-4-ones. Reddy, M.B.M., A. Nizam, and M.A. Pasha. Synthetic Communications, 2010. 40(24): p. 3728-3733; ISI[000284005600019].

[WOS]. HIV_1210-122110.

18. Convergent Assembly of the Spiroacetal Subunit of Didemnaketal B. Fuwa, H., S. Noji, and M. Sasaki. Organic Letters, 2010. 12(22): p. 5354-5357; ISI[000284080400071].

[WOS].HIV_1210-122110.

19. Synthesis of N-Terminally Linked Protein and Peptide Dimers by Native Chemical Ligation. Xiao, J.P., B.S. Hamilton, and T.J. Tolbert. Bioconjugate Chemistr, 2010. 21(11): p. 1943-1947; ISI[000284203200002].

[WOS].HIV_1210-122110.

20. Molecular mechanisms of retroviral integrase inhibition and the evolution of viral resistance. Hare, S., A.M. Vos, R.F. Clayton, J.W. Thuring, M.D. Cummings, and P. Cherepanov. Proceedings of the National Academy of Sciences of the United States of America, 2010. 107(46): p. 20057-20062; ISI[000284261800082].

[WOS].HIV_1210-122110.

21. Design, Synthesis, and Biological Evaluation of Novel Hybrid Dicaffeoyltartaric/Diketo Acid and Tetrazole-Substituted L-Chicoric Acid Analogue Inhibitors of Human Immunodeficiency Virus Type 1 Integrase. Crosby, D.C., X.Y. Lei, C.G. Gibbs, B.R. McDougall, W.E. Robinson, and M.G. Reinecke. Journal of Medicinal Chemistry, 2010. 53(22): p. 8161-8175; ISI[000284287200025].

[WOS].HIV_1210-122110.

22. Towards the synthesis of coumarin derivatives as potential dual-action HIV-1 protease and reverse transcriptase inhibitors. Olomola, T.O., R. Klein, K.A. Lobb, Y. Sayed, and P.T. Kaye. Tetrahedron Letters, 2010. 51(48): p. 6325-6328; ISI[000284303200032].

[WOS].HIV_1210-122110.

23. Discovery of N-benzyl-N '-(4-pipyridinyl)urea CCR5 antagonists as anti-HIV-1 agents (I): Optimization of the amine portion. Duan, M.S., J. Peckham, M. Edelstein, R. Ferris, W.M. Kazmierski, A. Spaltenstein, P. Wheelan, and Z.P. Xiong. Bioorganic & Medicinal Chemistry Letters, 2010. 20(24): p. 7397-7400; ISI[000284332900047].

[WOS].HIV_1210-122110.

24. QSAR analysis of some novel sulfonamides incorporating 1,3,5-triazine derivatives as carbonic anhydrase inhibitors. Jain, A.K., R. Veerasamy, A. Vaidya, V. Mourya, and R.K. Agrawal. Medicinal Chemistry Research, 2010. 19(9): p. 1191-1202; ISI[000284432000015].

[WOS]. HIV_1210-122110.

25. On the design of polymeric 5 '-O-ester prodrugs of 3 '-azido-2 ',3 '-dideoxythymidine (AZT). Troev, K.D., V.A. Mitova, and I.G. Ivanov. Tetrahedron Letters, 2010. 51(47): p. 6123-6125; ISI[000284435400014].

[WOS]., HIV_1210-122110.

26. Modified Rapid Screening Method for Evaluation of HIV-1 Protease Inhibitors. Hinkov, A., V. Atanasov, S. Raleva, and R. Argirova, . Comptes Rendus De L Academie Bulgare Des Sciences, 2010. 63(10): p. 1455-1462; ISI[000284440300009].

[WOS]. HIV_1210-122110.

27. Development of Peptide and Small-Molecule HIV-1 Fusion Inhibitors that Target gp41. Cai, L.F. and S.B. Jiang. ChemMedChem, 2010. 5(11): p. 1813-1824; ISI[000284585500002].

[WOS]. HIV_1210-122110.

28. Inhibition of HIV-1 Entry: Multiple Keys to Close the Door. Hertje, M., M.K. Zhou, and U. Dietrich. ChemMedChem, 2010. 5(11): p. 1825-1835; ISI[000284585500003].

[WOS]. HIV_1210-122110.

29. Probing Multidrug-Resistance and Protein-Ligand Interactions with Oxatricyclic Designed Ligands in HIV-1 Protease Inhibitors. Ghosh, A.K., C.X. Xu, K.V. Rao, A. Baldridge, J. Agniswamy, Y.F. Wang, I.T. Weber, M. Aoki, S.G.P. Miguel, M. Amano, and H. Mitsuya. ChemMedChem, 2010. 5(11): p. 1850-1854; ISI[000284585500008].

[WOS]. HIV_1210-122110.

30. Effects of Plant Extracts on HIV-1 Protease. Ribeiro, J., H.D. Falcao, L.M. Batista, J.M. Barbosa, and M.R. Piuvezam. Current HIV Research, 2010. 8(7): p. 531-544; ISI[000284622500007].

[WOS]. HIV_1210-122110.

31. Thiazolopyrimidines without bridge-head nitrogen: thiazolo 4,5-d pyrimidines. El-Bayouki, K.A.M. and W.M. Basyouni. Journal of Sulfur Chemistry, 2010. 31(6): p. 551-590; ISI[000284635800010].

[WOS].HIV_1210-122110.

32. Chemical Modifications Designed to Improve Peptide Stability: Incorporation of Non-Natural Amino Acids, Pseudo-Peptide Bonds, and Cyclization. Gentilucci, L., R. De Marco, and L. Cerisoli. Current Pharmaceutical Design, 2010. 16(28): p. 3185-3203; ISI[000284642000012].

[WOS].HIV_1210-122110.

33. Recent Patents on Nucleic Acid-Based Antiviral Therapeutics. Mishra, S., S. Kim, and D.K. Lee. Recent Patents on Anti-Cancer Drug Discovery, 2010. 5(3): p. 255-271; ISI[000284650400005].

[WOS].HIV_1210-122110.

34. Targeting Protein-Protein Interactions: A Promising Avenue of Anti-HIV Drug Discovery. Zhan, P., W.J. Li, H.F. Chen, and X.Y. Liu. Current Medicinal Chemistry, 2010. 17(29): p. 3393-3409; ISI[000284654100011].

[WOS].HIV_1210-122110.

35. Synthesis of fused dihydropyrido e purines via ring closing metathesis. Litinas, K.E. and A. Thalassitis. Tetrahedron Letters, 2010. 51(49): p. 6451-6453; ISI[000284664500022].

[WOS].HIV_1210-122110.

36. Partial selective inhibition of HIV-1 reverse transcriptase and human DNA polymerases gamma and p by thiated 3 '-fluorothymidine analogue 5 '-triphosphates. Winska, P., A. Miazga, J. Poznanski, and T. Kulikowski. Antiviral Research, 2010. 88(2): p. 176-181; ISI[000284680100006].

[WOS].HIV_1210-122110.

37. The efficient synthesis of (3R,3aS,6aR)-hexahydrofuro 2,3-b furan-3-ol and its isomers. Kulkarni, M.G., Y.B. Shaikh, A.S. Borhade, A.P. Dhondge, S.W. Chavhan, M.P. Desai, D.R. Birhade, N.R. Dhatrak, and R. Gannimani. Tetrahedron-Asymmetry, 2010. 21(19): p. 2394-2398; ISI[000284728400013].

[WOS].HIV_1210-122110.

38. Design, Synthesis, and Evaluation of Diarylpyridines and Diarylanilines as Potent Non-nucleoside HIV-1 Reverse Transcriptase Inhibitors. Tian, X.T., B.J. Qin, Z.Y. Wu, X.F. Wang, H. Lu, S.L. Morris-Natschke, C.H. Chen, S.B. Jiang, K.H. Lee, and L. Xie. Journal of Medicinal Chemistry, 2010. 53(23): p. 8287-8297; ISI[000284738400008].

[WOS].HIV_1210-122110.

39. Synthesis and biological activity of new pyridone diaryl ether non-nucleoside inhibitors of HIV-1 reverse transcriptase. Kennedy-Smith, J.J., N. Arora, J.R. Billedeau, J. Fretland, J.Q. Hang, G.M. Heilek, S.F. Harris, D. Hirschfeld, H. Javanbakht, Y. Li, W.L. Liang, R. Roetz, M. Smith, G.P. Su, J.M. Suh, A.G. Villasenor, J. Wu, D. Yasuda, K. Klumpp, and Z.K. Sweeney. MedChemComm, 2010. 1(1): p. 79-83; ISI[000284864200015].

[WOS].HIV_1210-122110.

40. Chemical constituents and biological applications of the genus Symplocos. Badoni, R., D.K. Semwal, S.K. Kothiyal, and U. Rawat. Journal of Asian Natural Products Research, 2010. 12(12): p. 1069-1080; ISI[000284891600009].

[WOS].HIV_1210-122110.